A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sang-Pyo | - |
dc.contributor.author | Kim, Sang-Heon | - |
dc.contributor.author | Kim, Tae Hyung | - |
dc.contributor.author | Sohn, Jang Won | - |
dc.contributor.author | Shin, Dong Ho | - |
dc.contributor.author | Park, Sung Soo | - |
dc.contributor.author | Yoon, Ho Joo | - |
dc.date.accessioned | 2024-01-10T02:06:03Z | - |
dc.date.available | 2024-01-10T02:06:03Z | - |
dc.date.issued | 2010-01 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.issn | 1598-6357 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/193893 | - |
dc.description.abstract | An 82-yr-old man was presented with fever and cough accompanied by generalized erythematous rash. He had taken mexiletine for 5 months, as he had been diagnosed with dilated cardiomyopathy and ventricular arrhythmia. Laboratory studies showed peripheral blood eosinophilia and elevated liver transaminase levels. Chest radiographs showed multiple nodular consolidations in both lungs. Biopsies of the lung and skin lesions revealed eosinophilic infiltration. After a thorough review of his medication history, mexiletine was suspected as the etiologic agent. After discontinuing the mexiletine and starting oral prednisolone, the patient improved, and the skin and lung lesions disappeared. Subsequently, mexiletine was confirmed as the causative agent based on a positive patch test. Drug-induced hypersensitivity syndrome is a severe adverse reaction to drugs and results from treatment with anticonvulsants, allopurinol, sulfonamides, and many other drugs. Several cases of mexiletine-induced hypersensitivity syndrome have been reported in older Japanese males with manifestation of fever, rash, peripheral blood eosinophilia, liver dysfunction without other organ involvement. Here, we report a case of mexiletine-induced hypersensitivity syndrome which presented as eosinophilic pneumonia in a Korean male. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.title | A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3346/jkms.2010.25.1.148 | - |
dc.identifier.scopusid | 2-s2.0-77949328502 | - |
dc.identifier.wosid | 000273367200026 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.25, no.1, pp 148 - 151 | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 25 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 148 | - |
dc.citation.endPage | 151 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001408092 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | STEVENS-JOHNSON-SYNDROME | - |
dc.subject.keywordPlus | DRUG-HYPERSENSITIVITY | - |
dc.subject.keywordPlus | REACTIVATION | - |
dc.subject.keywordPlus | ERUPTION | - |
dc.subject.keywordPlus | MARKER | - |
dc.subject.keywordAuthor | Drug Hypersensitivity | - |
dc.subject.keywordAuthor | Mexiletine | - |
dc.subject.keywordAuthor | Pulmonary Eosinophilia | - |
dc.identifier.url | https://jkms.org/DOIx.php?id=10.3346/jkms.2010.25.1.148 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.